Feb 02,2021 02:32 PM
Bharat Biotech selected as a partner based upon its established experience in development, production, and supply of globalhealth
Glaxosmithkline Consumer Healthcare Feb 10,2020
|Resolution Type||Description Of Resolution||IiAS Recommendation|
|Name||LTP||PE||Mar Cap||NP Qtr||Div. Yld||Sales Qtr||BV|
|Hindustan Unilever Ltd||2,376.85||68.71||558,445.28||2,143.00||1.70||11,947.00||201.88|
|Nestle India Ltd||17,224.15||76.88||166,004.24||602.25||1.16||3,600.20||209.44|
|Dabur India Ltd||535.00||68.39||94,521.91||300.27||1.22||1,721.86||30.50|
|Godrej Consumer Products Ltd||851.80||70.44||87,074.93||250.70||0.00||1,466.36||62.19|
|Britannia Industries Ltd||3,501.45||47.90||84,312.33||353.46||1.77||2,856.50||137.82|
Figures of Market Capital(Mar Cap), Quaterly Net Profit(NP Qtr) and Quaterly Sales(Sales Qtr) are in Cr.
GlaxoSmithKline Consumer Healthcare Ltd is one of the largest players in the Health Food Drinks industry in India. The company is an Indian associate of GlaxoSmithKline plc, UK, one of worlds largest consumer healthcare companies. The companys principal activities are to manufacture and distribute a wide range of healthcare foods, drugs, pharmaceuticals and dairy products. The products include malted milk food, malted foods, biscuits, ... More
Reports by glaxosmithkline-consumer-healthcare-ltd-share-price
May 15, 2021 01:09 AM
The company’s standalone revenue stood at Rs1,116.8cr, up 7.5% yoy but down 12.2% qoq.
No Records found